Page URL:
CONTENTS Issue #277
Ovarian transplant success is cause for celebration
BioNews Appeal: Please donate HERE to keep BioNews independent and FREE to read

You are currently viewing the Alert version of the BioNews email newsletter.

Click the tab above to view the Full Text version

Welcome to BioNews by email, published by the Progress Educational Trust, providing you with news, comment and reviews on genetics, assisted conception, embryo/stem cell research and related areas. 

Visit the BioNews website at where you can subscribe for free to receive BioNews by email in one of three formats, and search the archive of more than 8,000 articles.

Ovarian transplant success is cause for celebration
27 September 2004 - by Dr Jess Buxton
This week, BioNews reports on the world's first baby born following a transplant of frozen, thawed ovary tissue. This is the first success for a technique that promises to benefit thousands of women who would otherwise lose their fertility forever. Ouarda Touriat, who underwent lifesaving cancer treatment that left her... [Read More]
Inquiry into 'personalised medicine' launched
21 September 2004 - by BioNews
The UK's Royal Society is launching a year-long investigation into the potential of pharmacogenetics: drug treatments tailored to a person's genetic make-up. The study, headed by geneticist Sir David Weatherall, will look at when and if 'personalised medicine' will become a reality. It will also assess whether healthcare providers in... [Read More]
Bush presses UN for global cloning ban
24 September 2004 - by BioNews
President Bush has told the United Nations (UN) that he supports a UN draft resolution that would ban all forms of human cloning. The President's speech, to the UN General Assembly, took his belief in 'human dignity' as its theme. He spoke first about the situation in Iraq, before moving... [Read More]
First frozen ovary tissue birth
25 September 2004 - by BioNews
The first woman in the world to become pregnant following a transplant of her own frozen, thawed ovarian tissue has given birth to a healthy baby girl. In 1997, Ouarda Touirat, now aged 32, had parts of her ovaries removed before beginning treatment for Hodgkin's lymphoma that would leave her... [Read More]
Gene therapy trial for Alzheimer's disease
24 September 2004 - by BioNews
The first patient in a gene therapy trial for Alzheimer's disease, 63-year-old Ron Shellady, was treated recently at Rush University Medical Centre in Chicago, US. The two-year study will assess the safety of the technique, on 6-12 participants with a mild to moderate form of the disease. The... [Read More]
HFEA decides against licence fee increase
27 September 2004 - by BioNews
The Human Fertilisation and Embryology Authority (HFEA), which licenses all work carried out on human embryos in the UK, has decided to abandon its plans for a steep increase in licence fees. The authority proposed the fee changes earlier this year and sent them out for consultation before 30 June... [Read More]
Stem cells promise new disease treatments
27 September 2004 - by BioNews
US scientists have managed to grow human retina cells in the laboratory, using stem cells taken from early human embryos. The team, based at biotech firm Advanced Cell Technology (ACT), hope that their achievement will lead to new treatments for some forms of age-related vision loss. Meanwhile, an Israeli team... [Read More]
Referendum on Italy's fertility laws?
27 September 2004 - by BioNews
Italy may hold a referendum on whether its fertility laws should be overturned. The country's Radical Party have been collecting signatures and says that it is close to the required total of 500,000 signatures needed to call for the referendum. The drive to overturn the law has divided both main... [Read More]

Advertising in BioNews

BioNews is read by around 18,000 people every week. Our readership is predominantly in the UK, but we have subscribers in 44 countries. That is a lot of people with an interest in assisted conception, genetics, embryo/stem cell research and related areas.

Advertisements (up to 300 words in length) start from as little as £75, making BioNews a very cost effective way to reach your target audience.

The Progress Educational Trust can personally vouch for the service, as the charity has itself successfully engaged members of staff via BioNews. Why not save money by recruiting through BioNews, and help keep BioNews FREE at the same time?

If you would like further information about advertising a job or opportunity in BioNews, please contact Sarah Norcross on +44 (0)20 7278 7870 or at

Sarah Norcross
Director, Progress Educational Trust
140 Gray's Inn Road
London, WC1X 8AX